cyclosporine has been researched along with Carcinoma, Basal Cell, Pigmented in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (40.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Enk, AH; Hadaschik, EN; Lonsdorf, AS; Menzer, C; Neuberger, A; Volk, N | 1 |
| Codarin, FR; Festa Neto, C; Oliveira, WRP; Silva, LLC; Souza, AAV; Tirico, MCCP | 1 |
| Abramson, AK; Day, A; Menter, MA; Patel, M; Warren, RB | 1 |
| Abdelmalek, M; Cusack, CA; Doyle, A; Henien, M; Malat, G; Miller, B; Nijhawan, R | 1 |
| Akyazi, H; Alpay, K; Bahadir, S; Cobanoğlu, U; Yayli, S | 1 |
| Epstein, EH; Hebert, J; Hwang, J; Lu, Y; Vogt, A | 1 |
| Gralla, J; Moosa, MR | 1 |
| Abou Ayache, R; Bauwens, M; Belmouaz, M; Bridoux, F; Desport, E; Thierry, A; Touchard, G | 1 |
| Kautzky, F; Köhler, LD; Vogt, HJ | 1 |
| Bergfelt, L | 1 |
| Green, C; Hawk, JL | 1 |
| Veness, MJ | 1 |
| Otley, CC; Pittelkow, MR | 1 |
| Blohmé, I; Larkö, O | 1 |
| Garden, J; Pakula, A | 1 |
2 review(s) available for cyclosporine and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
The spectrum of oculocutaneous disease: Part II. Neoplastic and drug-related causes of oculocutaneous disease.
Topics: Aortic Coarctation; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comorbidity; Cyclosporine; Dermatologic Agents; Eye Abnormalities; Eye Diseases; Eyelid Neoplasms; Humans; Lymphoma, T-Cell, Cutaneous; Melanoma; Mohs Surgery; Multiple Myeloma; Neurocutaneous Syndromes; Retinoids; Sebaceous Gland Neoplasms; Skin Diseases; Skin Neoplasms; Stevens-Johnson Syndrome; Syndrome; Tumor Necrosis Factor-alpha | 2014 |
Skin cancer in liver transplant recipients.
Topics: Animals; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis; Liver Transplantation; Postoperative Complications; Skin Neoplasms; Tacrolimus | 2000 |
1 trial(s) available for cyclosporine and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
No difference in skin cancer incidence with or without cyclosporine--a 5-year perspective.
Topics: Azathioprine; Carcinoma in Situ; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Follow-Up Studies; Humans; Incidence; Keratoacanthoma; Kidney Transplantation; Prednisolone; Skin Neoplasms | 1992 |
12 other study(ies) available for cyclosporine and Carcinoma, Basal Cell, Pigmented
| Article | Year |
|---|---|
Expression of p53 up-regulated modulator of apoptosis (PUMA) in non-melanoma skin cancer of long-term immunosuppressed solid organ transplant recipients compared to immunocompetent patients.
Topics: Aged; Aged, 80 and over; Apoptosis Regulatory Proteins; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Female; Gene Expression Regulation, Neoplastic; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Organ Transplantation; Proto-Oncogene Proteins; Risk Factors; Skin Neoplasms; Ultraviolet Rays; Up-Regulation | 2021 |
Skin lesions in organ transplant recipients: a study of 177 consecutive Brazilian patients.
Topics: Adolescent; Adult; Aged; Azathioprine; Brazil; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Child; Cyclosporine; Dermatomycoses; Female; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Organ Transplantation; Risk Factors; Skin Diseases, Infectious; Skin Neoplasms; Tacrolimus; Warts; Young Adult | 2019 |
Vismodegib for locally advanced basal cell carcinoma in a heart transplant patient.
Topics: Aged; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Cyclosporine; Drug Monitoring; Facial Neoplasms; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Pyridines; Skin Neoplasms | 2015 |
Coexistence of basal cell carcinomas and multiple sebaceous gland hyperplasias in a cyclosporine (ciclosporin)-treated renal transplant recipient.
Topics: Carcinoma, Basal Cell; Cyclosporine; Face; Humans; Hyperplasia; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Nose; Sebaceous Gland Diseases; Skin Neoplasms; Treatment Outcome | 2010 |
Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice.
Topics: Animals; Carcinoma, Basal Cell; Cyclosporine; Disease Models, Animal; Glucocorticoids; Graft Rejection; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Knockout; Patched Receptors; Patched-1 Receptor; Prednisolone; Proteins; Receptors, Cell Surface; Skin Neoplasms | 2005 |
Skin cancer in renal allograft recipients--experience in different ethnic groups residing in the same geographical region.
Topics: Adult; Azathioprine; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Skin Neoplasms; South Africa; Sunlight; White People | 2005 |
Long-term maintenance of calcineurin inhibitor monotherapy reduces the risk for squamous cell carcinomas after kidney transplantation compared with bi- or tritherapy.
Topics: Adult; Calcineurin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Immunotherapy; Kidney Transplantation; Middle Aged; Retrospective Studies | 2007 |
[Multiple cutaneous neoplasms in cyclosporine therapy after kidney transplantation].
Topics: Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cell Transformation, Neoplastic; Cyclosporine; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Administration Schedule; Dysplastic Nevus Syndrome; Follow-Up Studies; Humans; Immune Tolerance; Kidney Transplantation; Male; Melanoma; Middle Aged; Neoplasms, Multiple Primary; Precancerous Conditions; Skin Neoplasms | 1995 |
Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
Topics: Adenosine Triphosphatases; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Animals; Antigens, CD; Azathioprine; Carcinoma, Basal Cell; Cell Adhesion Molecules; Cell Line, Transformed; Cell Movement; Cyclosporine; Female; HLA-DR Antigens; Humans; Immune Tolerance; Intercellular Adhesion Molecule-1; Langerhans Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Nude; Middle Aged; Monitoring, Immunologic; Neoplasm Transplantation; Neoplasms, Radiation-Induced; Prednisolone; PUVA Therapy; Skin; Skin Neoplasms; T-Lymphocytes; Ultraviolet Rays | 1993 |
Cutaneous malignancy related to cyclosporin A therapy.
Topics: Adult; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Humans; Male; Methotrexate; Psoriasis; Skin Neoplasms | 1993 |
Cardiac transplant-related cutaneous malignancies in an Australian recipient: immunosuppression, friend or foe?
Topics: Adult; Australia; Azathioprine; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cyclosporine; Glucocorticoids; Head and Neck Neoplasms; Heart Failure; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Myocardial Ischemia; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Opportunistic Infections; Prednisolone; Skin Neoplasms | 1998 |
Sebaceous hyperplasia and basal cell carcinoma in a renal transplant patient receiving cyclosporine.
Topics: Carcinoma, Basal Cell; Cyclosporine; Humans; Hyperplasia; Kidney Transplantation; Male; Middle Aged; Sebaceous Glands; Skin Neoplasms | 1992 |